Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Chemed Q3 2026 Results: Net Income $71.6M, Up 11.5% YoY

Chemed Corp reported a net income of $71.6 million for the third quarter of 2026, up from $64.2 million in the prior year, driven by service revenues of $690.9 million. For the nine months ended September 30, 2026, net income reached $205.7 million, while the company significantly increased its long-term debt to $236 million and expanded its goodwill through business combinations.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue690.9624.9
Profit before tax96.783.5
Net income71.664.2
EPS (diluted, $ a share)$5.45$4.46

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year+11.5%
Revenue, year on year+10.6%
Operating margin14.0%
Source

10-Q filed with the SEC, NYSE: CHE. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Chemed Corp: key numbers

Share price
$549.45Close, Nov 16
Market cap
$7.15B
Shares outstanding
13.01MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Home Health Care ServicesSIC 8082

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Chemed Corp

All →
11:19 AM ET Form 4
Insider Selling

Chemed EVP Spencer S. Lee Sells $548K of Stock

Spencer S. Lee, EVP, sold 1,000 shares of Chemed Corp at $547.61 a share, worth $548K in total on Nov 11, 2026. Shares held after the trade: 12,931 (-7.2%).

Value
$548K
Shares
1,000
Price
$547.61
Role
EVP
Holding change
-7.2%
Trade date
Nov 11, 2026
3:35 PM ET Form 4
Insider Selling

Chemed president and CEO Kevin J. Mcnamara Sells $1.08M of Stock

Kevin J. Mcnamara, president and CEO, sold 2,000 shares of Chemed Corp at $537.90 a share, worth $1.08M in total on Nov 3, 2026. Shares held after the trade: 82,220 (-2.4%).

Value
$1.08M
Shares
2,000
Price
$537.90
Role
president and CEO
Holding change
-2.4%
Trade date
Nov 3, 2026
1:11 PM ET Form 4
Insider Selling

Chemed EVP Spencer S. Lee Sells $494K of Stock

Spencer S. Lee, EVP, sold 920 shares of Chemed Corp at $537.17 a share, worth $494K in total on Nov 2, 2026. Shares held after the trade: 13,931 (-6.2%).

Value
$494K
Shares
920
Price
$537.17
Role
EVP
Holding change
-6.2%
Trade date
Nov 2, 2026
4:30 PM ET 8-K
Financial Results

Chemed Financial Results

Chemed Corporation reported third-quarter 2026 consolidated revenue of $690.9 million, a 10.6% increase year-over-year, driven by strong performance in its VITAS Healthcare segment. GAAP diluted EPS rose 22.2% to $5.45, while the VITAS segment saw a 12.2% increase in net patient revenue and a significant expansion in Adjusted EBITDA margins.

Term
Q3 2026
2:07 PM ET Form 4
Insider Selling

Chemed president and CEO Kevin J. Mcnamara Sells $1.03M of Stock

Kevin J. Mcnamara, president and CEO, sold 2,000 shares of Chemed Corp at $513.45 a share, worth $1.03M in total on Sep 28, 2026. Shares held after the trade: 66,418 (-2.9%).

Value
$1.03M
Shares
2,000
Price
$513.45
Role
president and CEO
Holding change
-2.9%
Trade date
Sep 28, 2026
12:24 PM ET Form 4
Insider Selling

Chemed president and CEO Kevin J. Mcnamara Sells $1M of Stock

Kevin J. Mcnamara, president and CEO, sold 2,000 shares of Chemed Corp at $501.40 a share, worth $1M in total on Sep 18, 2026. Shares held after the trade: 68,418 (-2.8%).

Value
$1M
Shares
2,000
Price
$501.40
Role
president and CEO
Holding change
-2.8%
Trade date
Sep 18, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.